Related Experiment Video
Updated: May 7, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Cladribine Use in Relapsing Multiple Sclerosis After 8-10 Years: Two Case Reports of Patients From the ORACLE-MS
Miguel Angel Hernandez1, Rossana Abreu Rodriguez1, Yessica Contreras Martin1
1Neurology, Multiple Sclerosis Unit, University Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, ESP.
Two relapsing multiple sclerosis (MS) patients achieved long-term disease remission with a second course of cladribine, an immune reconstitution therapy. This real-world evidence supports cladribine
Area of Science:
- Neuroimmunology
- Clinical Neurology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Immune reconstitution therapies aim to restore immune balance.
- Cladribine is an oral immune reconstitution therapy for relapsing MS.
More Related Videos
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
08:57Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015